Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Heart Surg Forum ; 24(1): E019-E021, 2021 01 14.
Article in English | MEDLINE | ID: covidwho-1079393


Pneumonia caused by coronavirus disease 2019 (COVID-19) is a highly contagious disease. Unfortunately, research on extracorporeal membrane oxygenation (ECMO) assisted treatments for patients with COVID-19 infection is limited. In this case study, a patient who was in late pregnancy (35+2 weeks of pregnancy) and suffering from severe COVID-19 was extremely irritable during ECMO-assisted treatment after she underwent a cesarean section. Her Richmond Agitation Sedation Scale (RASS) score reached +3. Nevertheless, the patient successfully was treated with a continuous single/combined application of propofol, midazolam, dexmedetomidine, hibernation mixture, and other drugs for several days (maintaining RASS -2 to -4) and provided with anti-infection, mechanical ventilation, nutritional support, fluid balance under hemodynamic monitoring, liver support, and other organ function support treatments. ECMO-assisted sedation strategy for patients was introduced and discussed in this case to provide a certain reference for the clinical diagnosis and treatment of such patients.

COVID-19/therapy , Cesarean Section , Dexmedetomidine/administration & dosage , Extracorporeal Membrane Oxygenation , Hypnotics and Sedatives/administration & dosage , Midazolam/administration & dosage , Propofol/administration & dosage , Combined Modality Therapy , Female , Fluid Therapy , Humans , Monitoring, Physiologic , Nutritional Support , Pregnancy , Respiration, Artificial , SARS-CoV-2